Skin Dermal Regeneration After Stromal… | Clinical Trial

Key information

Conditions

Skin Regeneration

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine

Shanghai, Huangpu, 200011, China

About this study

This study is a prospective, exploratory investigation aimed at exploring the efficacy of stromal vascular fraction (SVF) transplantation in treating exhaustion of dermal regenerative capacity during skin expansion. The dermal thickness, texture, and perfusion before and after SVF transplantation would be recorded and analyzed by a series of quantitative devices including laser 3D scanner, Doppler ultrasound, VISIA skin analyzer, CK skin analyzer, and indocyanine green angiography.

The trial aims to include patients experiencing dermal exhaustion during the process of skin soft tissue expansion. We will extract SVF components from autologous adipose tissue and injected intradermally into the expanded skin. The changes of dermis of expanded skin were recorded before the treatment (baseline), and at 4 weeks and 8 weeks follow-up timepoints after SVF transplantation. More specifically, skin surface area was measured using laser 3D scan; skin thickness and texture were detected by Doppler ultrasound, VISIA skin analyzer and CK skin analyzer; skin blood perfusion was analyzed using indocyanine green angiography.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

had undergone tissue expansion treatment;
show signs of deterioration of skin texture during expansion, including stretch marks or thinning of the dermis (<2mm) with no improvement after suspending expansion for 2 weeks;
require further expansion to achieve the size for defect reconstruction.

Exclusion criteria

Patients with serious underlying diseases such as cardiovascular or cerebrovascular disease, peripheral vascular disease, or impaired liver or kidney function;
Patients with a long history of smoking and alcohol use who have not quit smoking or drinking;
Patients allergic to iodine or iodine-containing preparations;
Patients with psychiatric disorders, lack of insight, or those who cannot accurately express themselves or cooperate;
Patients with contraindications for SVF transplantation, such as ulceration or infection of the expanded skin;
Patients with severely loose skin or insufficient subcutaneous fat tissue;
Patients who request to withdraw informed consent and exit the clinical trial.

Treatment and study plan

Stromal vascular fraction transplantation

Procedure

Stromal vascular fraction was extracted from subcutaneous fat harvested from either the abdomen or the posterior inner thigh region. The SVF cell-pellet was washed and was adjusted to 2×10^6 cells/mL. The skin was marked with methylene blue and a total of 0.5ml (around 1×10^6 cells) were transplanted intradermally at the center of each 2cm×2cm squares.

The expander was inflated two times a week using constant pressure inflation method, where the intracapsular pressure was monitored using a pressure meter and the inflation was halted when the pressure reached 100 mmHg. This procedure was repeated until adequate skin area was achieved for subsequent facial restoration surgery.

Primary outcomes

Dermal thickness

Time frame: Baseline: before SVF transplantation (Baseline); Follow-up: 4 and 8 weeks after SVF transplantation

Using Doppler ultrasound to measure the full-thickness of skin dermis of the expanded skin. The measurements were conducted at the center of the expanded skin and other four points (above, below, left, right) around the center. The average value is taken to represent the dermal thickness of the patient's expanded skin.

Secondary outcomes

Skin surface area

Time frame: Baseline: before SVF transplantation (Baseline); Follow-up: 4 and 8 weeks after SVF transplantation

Using the HSCAN771 handheld laser 3D scanner and the VIVID910 3D laser scanning system to measure the surface area of the expanded skin.

Other outcomes

Skin texture (dermal rupture)

Time frame: Baseline: before SVF transplantation (Baseline); Follow-up: 4 and 8 weeks after SVF transplantation

Using the VISIA skin analyzer to visualize the distribution of dermal marks, which is an indication of dermal rupture. Briefly, photographs of the patient's expanded skin were taken from three standard angles: front, left side, and right side. Use the VISIA instrument to generate texture imaging of the expanded skin, selecting the expanded skin and surrounding normal skin as the region of interest. Employ the instrument's built-in red area analysis function to analyze the distribution of dermal marks in the expanded skin.
Skin texture (elasticity)

Time frame: Baseline: before SVF transplantation (Baseline); Follow-up: 4 and 8 weeks after SVF transplantation

Using the elasticity probe (Cutometer® MPA 580) of CK Skin analyzer to measure the elasticity of the expanded skin. Represent skin softness through the skin viscoelasticity parameter R2 (R2 = Ua/Uf, where Ua is the total elastic and plastic recovery, and Uf is the total elastic and plastic deformation). An R2 value closer to 1 indicates better skin elasticity. The measurements were conducted at the center of the expanded skin and other four points (above, below, left, right) around the center. Each point is measured three times, and the average value is taken to represent the measurement for that point.
Skin perfusion

Time frame: Baseline: before SVF transplantation (Baseline); Follow-up: 4 and 8 weeks after SVF transplantation

Indocyanine green (ICG) angiography was used to detect the blood perfusion of the expanded skin. Briefly, the detector of SPY imaging system was adjusted to approximately 20 cm from the surface of the flap. A white light photograph of the expanded skin was taken. Without changing the detector position, indocyanine green imaging was performed as follows: Inject 2 ml of ICG solution (2.5 mg/ml) intravenously and fluorescence signals from the expanded skin were collected by SPY imaging system. The integrated SPY-Q software was used for the analysis of the arterial and venous perfusion of the expanded flap.

Sponsors and collaborators

Lead sponsor

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Other

Registry information

Official study title

Quantitative Measurements of the Skin Dermal Regeneration After Stromal Vascular Fraction Transplantation

Acronym: SDR-SVF

Important dates

Study start: 2023
Primary completion: 2023
Study completion: 2024
First posted: Jun 3, 2024
Registry last updated: Jun 3, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting

The Effect of Stromal Vascular Fraction Transplantation on the Regeneration of Expanded Skin

NCT07114692